Chelvanambi, Sarvesh
Dr. Sarvesh Chelvanambi obtained his B.A in Zoology with a minor in Finance at Miami University (Ohio) in 2011, and his Masters in Biotechnology at The Pennsylvania State University in 2013. Sarvesh completed his PhD at Indiana University School of Medicine in the lab of Dr. Matthias Clauss in 2019. He studied the role of extracellular vesicles in promoting HIV related endothelial dysfunction which could be rescued with statin treatment. Sarvesh has always had a special place in his heart for communicating complex scientific ideas to a broad audience without diluting the underlying message. This stems from his experience representing Miami University’s Speech and Debate team for four years at national-level competitions and while presenting his research at various international conferences. Sarvesh has won the 3 Minute Thesis competition at IUPUI and was the sole representation for his University at the Midwestern Association of Graduate Students conference in 2019.
Sarvesh joined Dr. Masanori Aikawa’s research group at CICS as a Post doctoral Research Fellow in December of 2019. Sarvesh’s project will investigate whether viral proteins alter macrophage heterogeneity and serve as a major contributor towards the increased prevalence of cardiovascular diseases amongst patients.
Publications
Show
Iwata A, Chelvanambi S, Asano T, Whelan M, Nakamura Y, Aikawa E, Sasaki Y, Aikawa M
Gene expression profiles of precursor cells identify compounds that reduce NRP1 surface expression in macrophages: Implication for drug repositioning for COVID-19.
Chelvanambi S, Decano JL, Winkels H, Giannarelli C, Aikawa M
Decoding Macrophage Heterogeneity to Unravel Vascular Inflammation as a Path to Precision Medicine.
Matamalas JT, Chelvanambi S, Decano JL, França RF, Halu A, Santinelli-Pestana DV, Aikawa E, Malhotra R, Aikawa M
Obesity and age are transmission risk factors for SARS-CoV-2 infection among exposed individuals.
Decano JL, Maiorino E, Matamalas JT, Chelvanambi S, Tiemeijer BM, Yanagihara Y, Mukai S, Jha PK, Pestana DVS, D'Souza E, Whelan M, Ge R, Asano T, Sharma A, Libby P, Singh SA, Aikawa E, Aikawa M
Cellular Heterogeneity of Activated Primary Human Macrophages and Associated Drug-Gene Networks: From Biology to Precision Therapeutics.
Bartoli-Leonard F, Chelvanambi S, Pham T, Turner ME, Blaser MC, Caputo M, Aikawa M, Pang A, Muehlschlegel J, Aikawa E
Single-cell T cell receptor sequencing of paired tissue and blood samples reveals clonal expansion of CD8+ effector T cells in patients with calcific aortic valve disease.
Decano JL, Iwamoto Y, Goto S, Lee JY, Matamalas JT, Halu A, Blaser M, Lee LH, Pieper B, Chelvanambi S, Silva-Nicolau J, Bartoli-Leonard F, Higashi H, Shibata H, Vyas P, Wang J, Gostjeva E, Body SC, Singh SA, Aikawa M, Aikawa E
A disease-driver population within interstitial cells of human calcific aortic valves identified via single-cell and proteomic profiling.
Asano T, Chelvanambi S, Decano JL, Whelan MC, Aikawa E, Aikawa M
In silico Drug Screening Approach Using L1000-Based Connectivity Map and Its Application to COVID-19.
Rogers MA, Atkins SK, Zheng KH, Singh SA, Chelvanambi S, Pham TH, Kuraoka S, Stroes ESG, Aikawa M, Aikawa E
Lipoprotein(a) Induces Vesicular Cardiovascular Calcification Revealed With Single-Extracellular Vesicle Analysis.
Decano JL, Singh SA, Bueno CG, Lee LH, Halu A, Chelvanambi S, Matamalas JT, Zhang H, Mlynarchik AK, Qiao J, Sharma A, Mukai S, Wang J, Anderson DG, Ozaki CK, Libby P, Aikawa E, Aikawa M
Systems Approach to Discovery of Therapeutic Targets for Vein Graft Disease PPARα Pivotally Regulates Metabolism, Activation, and Heterogeneity of Macrophages and Lesion Development.
Brandão SCS, Ramos JOX, Dompieri LT, Godoi ETAM, Figueiredo JL, Sarinho ESC, Chelvanambi S, Aikawa M
Is Toll-like receptor 4 involved in the severity of COVID-19 pathology in patients with cardiometabolic comorbidities?
